contact us on e-mail: we@nosamplio.com
contact us on e-mail: we@nosamplio.com
we have supported numerous human health brands including medicines, injectables, medical devices, aesthetics devices, cosmetics, botanicals & nutraceuticals.
Rx and private-pay specialists.
we provide professional insight for human health projects including strategic planning, market access, patient access, launch, re-launch & mature commercial strategies.
we have sector expertise supporting Korean, Taiwanese, Chinese & Japanese companies reach their target audience in Europe,
MENA & the Americas.
ATGC Co., Ltd. License Agreement Grants RELIFE S.r.l. Exclusive Rights to Register, Promote, Distribute, and Market the Novel Botulinum Toxin Type A (ATGC-100) in Europe and the United Kingdom. www.relifecompany.com
Nosamplio provided ATGC with specialist pharmaceutical out-licensing consultancy to secure the Exclusive European Licensing Agreement with RELIFE
ATGC is an advanced biotechnology company, Korea based R&D with a pipeline of pharmaceutical projects. ATGC developed ATGC-100 a novel botulinum toxin type A for medical aesthetics indications www.atgcbio.com
Business development services for a large-cap Korean pharmaceutical company
Business development & Licensing for Korean pharmaceutical companies
Highly effective, easy-to-drink bowel preparation, on-the-day of colonoscopy for patient convenience
Licensing Life Science©
Founding Principal
mob: +44 7714 777 727
Giuseppe is a qualified medical practitioner with extensive Country specific pharmaceutical compliance experience
Frankie has extensive European & global pharmaceutical marketing experience. He provides clients with strategic marketing
and forecasting insights
Zak provides client business development. His experience includes pharmaceutical licensing, orphan drugs and life science business intelligence services
Phil has significant pharmaceutical & medical device partnerships experience. He provides nosamplio clients with support for Business Development & Licensing projects
Steve is MD of Audience Healthcare a markets & target customer insights provider
Harrison provides in-house social, digital and traditional marketing and communications services for our clients
Jack provides in-house legal expertise.
His experience includes
pharmaceutical intellectual property.
Jack is LLB Law (York, Eng).
medical device and pharmaceutical business development & licensing solutions
Nosamplio Limited
Registered in England, Company number 12034395
EORI: GB344603024000. ICO Registered ZB113191
© 2018 Nosamplio Limited - All Rights Reserved
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.